2023

1. Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia

   Blood Advances, Vol. 7, Núm. 1, pp. 167-173

2. Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes

   Leukemia Research, Vol. 134